These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18472953)

  • 1. Effect of Platelet-activating Factor on in vitro and in vivo Interleukin-6 Production.
    Pignol B; Maisonnet T; Guinot P; Mencia-Huertac JM; Braquet P
    Mediators Inflamm; 1994; 3(4):281-5. PubMed ID: 18472953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor modulates interleukin-6 production by mouse fibroblasts.
    Braquet P; Pignol B; Maisonnet T; Mencia-Huerta JM
    Int Arch Allergy Appl Immunol; 1991; 94(1-4):165-6. PubMed ID: 1937867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1beta stimulates platelet-activating factor production in U-937 cells modulating both its biosynthetic and catabolic enzymes.
    Vlachogianni IC; Nomikos T; Fragopoulou E; Stamatakis GM; Karantonis HC; Antonopoulou S; Demopoulos CA
    Cytokine; 2013 Aug; 63(2):97-104. PubMed ID: 23673285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor enhances interleukin-6 production by alveolar macrophages.
    Thivierge M; Rola-Pleszczynski M
    J Allergy Clin Immunol; 1992 Nov; 90(5):796-802. PubMed ID: 1331218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines and neutrophils as important mediators of platelet-activating factor-induced kinin B1 receptor expression.
    Fernandes ES; Passos GF; Campos MM; de Souza GE; Fittipaldi JF; Pesquero JL; Teixeira MM; Calixto JB
    Br J Pharmacol; 2005 Sep; 146(2):209-16. PubMed ID: 16025141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of long-term treatment with platelet-activating factor on cytokine production by rat spleen cells.
    Pignol B; Hénane S; Mencia-Huerta JM; Braquet P
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):161-3. PubMed ID: 2785086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of long-term treatment with platelet-activating factor on IL-1 and IL-2 production by rat spleen cells.
    Pignol B; Hénane S; Sorlin B; Rola-Pleszczynski M; Mencia-Huerta JM; Braquet P
    J Immunol; 1990 Aug; 145(3):980-4. PubMed ID: 2373865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-induced interleukin-6 and interleukin-8 production is mediated by platelet-activating factor and platelet-derived growth factor in primary human lung cells.
    Tamm M; Bihl M; Eickelberg O; Stulz P; Perruchoud AP; Roth M
    Am J Respir Cell Mol Biol; 1998 Oct; 19(4):653-61. PubMed ID: 9761763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor stimulates interleukin-6 production by human endothelial cells and synergizes with tumor necrosis factor for enhanced production of granulocyte-macrophage colony stimulating factor.
    Lacasse C; Turcotte S; Gingras D; Stankova J; Rola-Pleszczynski M
    Inflammation; 1997 Apr; 21(2):145-58. PubMed ID: 9187959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-activating factor and prostaglandin E2 impair esophageal ACh release in experimental esophagitis.
    Cheng L; Cao W; Fiocchi C; Behar J; Biancani P; Harnett KM
    Am J Physiol Gastrointest Liver Physiol; 2005 Sep; 289(3):G418-28. PubMed ID: 15890711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of interleukin-2 and interleukin-4 on immunomodulatory role of platelet-activating factor in human B cells.
    Patke CL; Green CG; Shearer WT
    Clin Diagn Lab Immunol; 1994 Jul; 1(4):424-32. PubMed ID: 8556480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet Activating Factor (PAF) biosynthesis is inhibited by phenolic compounds in U-937 cells under inflammatory conditions.
    Vlachogianni IC; Fragopoulou E; Stamatakis GM; Kostakis IK; Antonopoulou S
    Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt B):176-83. PubMed ID: 26358846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of platelet-activating factor with rat hepatocytes: uptake, translocation, metabolism, and effects on PAF-acetylhydrolase secretion and protein tyrosine phosphorylation.
    Svetlov SI; Howard KM; Miwa M; Flickinger BD; Olson MS
    Arch Biochem Biophys; 1996 Mar; 327(1):113-22. PubMed ID: 8615681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-activating factor (PAF-acether) enhances the concomitant production of tumour necrosis factor-alpha and interleukin-1 by subsets of human monocytes.
    Poubelle PE; Gingras D; Demers C; Dubois C; Harbour D; Grassi J; Rola-Pleszczynski M
    Immunology; 1991 Feb; 72(2):181-7. PubMed ID: 2016118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential signaling pathways in platelet-activating factor-induced proliferation and interleukin-6 production by rat vascular smooth muscle cells.
    Gaumond F; Fortin D; Stankova J; Rola-Pleszczynski M
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):169-75. PubMed ID: 9269943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-Activating Factor Deteriorates Lysophosphatidylcholine-Induced Demyelination Via Its Receptor-Dependent and -Independent Effects.
    Tian Z; Chu T; Shields LBE; Zhu Q; Zhang YP; Kong M; Barnes GN; Wang Y; Shields CB; Cai J
    Mol Neurobiol; 2020 Oct; 57(10):4069-4081. PubMed ID: 32661728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor.
    Bennett SA; Birnboim HC
    Mol Carcinog; 1997 Dec; 20(4):366-75. PubMed ID: 9433481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulatory effect of interleukin-10 on the production of platelet-activating factor and superoxide anions by human leucocytes.
    Bussolati B; Mariano F; Montrucchio G; Piccoli G; Camussi G
    Immunology; 1997 Mar; 90(3):440-7. PubMed ID: 9155653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paricalcitol effects on activities and metabolism of platelet activating factor and on inflammatory cytokines in hemodialysis patients.
    Verouti SN; Tsoupras AB; Alevizopoulou F; Demopoulos CA; Iatrou C
    Int J Artif Organs; 2013 Feb; 36(2):87-96. PubMed ID: 23335378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the platelet-activating factor antagonist, BN 52021, on human natural killer cell-mediated cytotoxicity.
    Mandi Y; Farkas G; Koltai M; Beladi I; Mencia-Huerta JM; Braquet P
    Immunology; 1989 Jul; 67(3):370-4. PubMed ID: 2759659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.